SMYD3 and liver cancer: In summary, our study demonstrates that SMYD3 specifically associates with the NuRD (MTA1/2) complex to form a complex in liver cancer cells, providing new insights into how SMYD3 regulates transcription by coordinating with distinct partner protein complexes.